Literature DB >> 9616494

Rapid recurrence of pulmonary hypertension following cessation of nifedipine.

M M Gallagher1, C M Hart, C J Vaughan, W H Fennell.   

Abstract

In a young woman with primary pulmonary hypertension, treatment with low-dose nifedipine resulted in resolution of symptoms and of tricuspid regurgitation. On withdrawal of nifedipine, symptomatic pulmonary hypertension recurred within 48 hours and was controlled by reintroduction of low-dose nifedipine.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9616494      PMCID： PMC2360804          DOI： 10.1136/pgmj.74.868.111

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  7 in total

1.  Remission of primary pulmonary hypertension during treatment with diazoxide.

Authors:  D R Hall
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-04

2.  Rapid attenuation of response to nifedipine in primary pulmonary hypertension.

Authors:  B A Wood; F Tortoledo; J C Luck; W H Fennell
Journal:  Chest       Date:  1982-12       Impact factor: 9.410

3.  The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.

Authors:  S Rich; E Kaufmann; P S Levy
Journal:  N Engl J Med       Date:  1992-07-09       Impact factor: 91.245

4.  Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxide.

Authors:  N S Chan; J McLay; A C Kenmure
Journal:  Br Heart J       Date:  1987-02

5.  Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

Authors:  G E D'Alonzo; R J Barst; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; J T Kernis
Journal:  Ann Intern Med       Date:  1991-09-01       Impact factor: 25.391

6.  High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.

Authors:  S Rich; B H Brundage
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

7.  Factors that influence the outcome of primary pulmonary hypertension.

Authors:  A Rozkovec; P Montanes; C M Oakley
Journal:  Br Heart J       Date:  1986-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.